Cargando…
敏感驱动基因阳性非小细胞肺癌脑膜转移药物治疗的管理
Leptomeningeal metastasis (LM) is one of the serious complications of advanced non-small cell lung cancer (NSCLC), although the incidence is not high, the clinical symptoms are severe and the prognosis is poor. LM is prone to occur in patients with positive driver gene than negative. At present, the...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467993/ https://www.ncbi.nlm.nih.gov/pubmed/32758347 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.18 |
Ejemplares similares
-
驱动基因阳性非小细胞肺癌免疫治疗进展
Publicado: (2022) -
驱动基因阴性非小细胞肺癌脑转移免疫治疗的研究进展
Publicado: (2018) -
驱动基因阳性肺癌脑转移患者的靶向治疗进展
Publicado: (2019) -
非小细胞肺癌脑膜转移诊疗现状
Publicado: (2015) -
晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
Publicado: (2017)